Environmental endocrine disruptors: Effects on the human male reproductive system M. F. Sweeney & N. Hasan & A. M. Soto & C. Sonnenschein Rev Endocr Metab Disord. 2016 Feb 4. [Epub ahead of print] Background […]
CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer? Abreu MH, Gomes M, Menezes F, Afonso N, Abreu PH, Medeiros R, Pereira D, Lopes C. Breast. 2015 Aug;24(4):481-6. doi: 10.1016/j.breast.2015.04.010. Epub […]
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer Robinson D, Garmo H, Holmberg L, Stattin P Cancer Causes Control. 2015 Jun 25. [Epub ahead of print] PMID: 26109464 Background I show this […]
Aromatase inhibitors in male breast cancer: a pooled analysis Zagouri F, Sergentanis TN, Azim HA Jr, Chrysikos D, Dimopoulos MA, Psaltopoulou T Breast Cancer Res Treat. 2015 May;151(1):141-7. doi: 10.1007/s10549-015-3356-9. Epub 2015 Apr 8. Background […]
Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, […]
Estrogen receptor mutations and their role in breast cancer progression Prasanna G Alluri, Corey Speers and Arul M Chinnaiyan Breast Cancer Research 2014, 16:494 doi:10.1186/s13058-014-0494-7 Background About 75% of breast cancers are hormone positive, and […]
Incidence of breast cancer in a cohort of 5,135 transgender veterans George R. Brown and Kenneth T. Jones Breast Cancer Res Treat DOI 10.1007/s10549-014-3213-2 Background Most breast cancers are hormone driven, at least at first, […]
Entering a World of Pink 